1. Home
  2. BLRX vs MOGU Comparison

BLRX vs MOGU Comparison

Compare BLRX & MOGU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLRX
  • MOGU
  • Stock Information
  • Founded
  • BLRX 2003
  • MOGU 2011
  • Country
  • BLRX Israel
  • MOGU China
  • Employees
  • BLRX N/A
  • MOGU N/A
  • Industry
  • BLRX Biotechnology: Pharmaceutical Preparations
  • MOGU Business Services
  • Sector
  • BLRX Health Care
  • MOGU Consumer Discretionary
  • Exchange
  • BLRX Nasdaq
  • MOGU Nasdaq
  • Market Cap
  • BLRX 17.2M
  • MOGU 19.8M
  • IPO Year
  • BLRX 2011
  • MOGU 2018
  • Fundamental
  • Price
  • BLRX $3.75
  • MOGU $4.14
  • Analyst Decision
  • BLRX Strong Buy
  • MOGU
  • Analyst Count
  • BLRX 2
  • MOGU 0
  • Target Price
  • BLRX $19.00
  • MOGU N/A
  • AVG Volume (30 Days)
  • BLRX 32.4K
  • MOGU 3.7M
  • Earning Date
  • BLRX 08-14-2025
  • MOGU 07-21-2025
  • Dividend Yield
  • BLRX N/A
  • MOGU N/A
  • EPS Growth
  • BLRX N/A
  • MOGU N/A
  • EPS
  • BLRX N/A
  • MOGU N/A
  • Revenue
  • BLRX $17,251,000.00
  • MOGU $19,462,964.00
  • Revenue This Year
  • BLRX N/A
  • MOGU N/A
  • Revenue Next Year
  • BLRX N/A
  • MOGU N/A
  • P/E Ratio
  • BLRX N/A
  • MOGU N/A
  • Revenue Growth
  • BLRX 1.19
  • MOGU N/A
  • 52 Week Low
  • BLRX $2.30
  • MOGU $1.83
  • 52 Week High
  • BLRX $26.80
  • MOGU $8.10
  • Technical
  • Relative Strength Index (RSI)
  • BLRX 49.78
  • MOGU 63.39
  • Support Level
  • BLRX $3.68
  • MOGU $4.10
  • Resistance Level
  • BLRX $4.11
  • MOGU $5.50
  • Average True Range (ATR)
  • BLRX 0.25
  • MOGU 0.64
  • MACD
  • BLRX 0.02
  • MOGU 0.15
  • Stochastic Oscillator
  • BLRX 44.15
  • MOGU 33.85

About BLRX BioLineRx Ltd.

BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has a legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.

About MOGU MOGU Inc.

MOGU Inc is an online service provider in China, operating a KOL-driven online fashion and lifestyle platform, Mogujie, and providing customized online branding solutions to businesses. The company, on its platform, provides content related to fashion and lifestyle guides in various multimedia formats, which include Live Video Broadcasts, Short-form Videos, Photography, and an Online Review Community. The company derives revenues from within China. It also provides online marketing, commission, financing, technology, and other relevant services to merchants and users, as well as technology services to brand owners.

Share on Social Networks: